MICROSATELLITE STABLE COLORECTAL CANCER
Clinical trials for MICROSATELLITE STABLE COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE STABLE COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for MICROSATELLITE STABLE COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental virus injection takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new treatment called VET3-TGI, a virus designed to infect and kill cancer cells. It is given alone or with an immunotherapy drug (atezolizumab) to about 60 adults with advanced solid tumors that have not responded to standard treatments. The main go…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE1 • Sponsor: KaliVir Immunotherapeutics • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
New hope for advanced cancers: experimental drug enters human trials
Disease control Recruiting nowThis study tests a new drug, BMS-986340, alone or with other cancer treatments (nivolumab or docetaxel) in people with advanced solid tumors that have worsened after standard therapy. The goal is to find safe doses and understand side effects. About 949 adults with various cancer…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New drug FOG-001 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug, FOG-001, in about 595 people with advanced solid tumors that have not responded to other treatments. The goal is to see if FOG-001 is safe and can shrink tumors or slow their growth. The trial focuses on several cancer types, including colorectal, pro…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated May 11, 2026 20:46 UTC